LA JOLLA DIAGNOSTICS INC
NT 10-K, 1998-11-13
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: MEMC ELECTRONIC MATERIALS INC, 10-Q, 1998-11-13
Next: IAS COMMUNICATIONS INC, 8-K, 1998-11-13





                SECURITIES AND EXCHANGE COMMISSION
                       Washington, DC 20549

                            FORM 12b-25

                    Notification of Late Filing

                  Commission File Number: 0-26108
                             -------
(Check one)

[ ]  Form 10-K and Form 10-KSB  
[ ]  Form 11-K  
[ ]  Form 20-F  
[X]  Form 10-Q and Form 10-QSB  
[ ]  Form N-SAR

     For the period ended September 30, 1998

 [ ]  Transition Report on Form 10-K and Form 10-KSB 
 [ ]  Transition Report on Form 20-F 
 [ ]  Transition Report on Form 11-K 
 [ ]  Transition Report on Form 10-Q and Form 10-QSB 
 [ ]  Transition Report on Form N-SAR

         For the transition period ended ____________

Nothing in this form shall be construed to imply that the 
Commission has verified any information contained herein.

         If the notification relates to a portion of the filing 
checked above, identify the item(s) to which notification 
relates:
__________________________________


                               PART I
                        REGISTRANT INFORMATION

Full name of registrant:      La Jolla Diagnostics Inc.

Former name if applicable:

Address of principal
executive office:             7777 Fay Avenue,Suite 160

City, State and Zip Code:     La Jolla, California 92037


<PAGE>

                              PART II

                       RULE 12b-25(b) and (c)

         If the subject report could not be filed without 
unreasonable effort or expense and the registrant seeks relief 
pursuant to Rule 12b-25(b), the following should be completed. 
(Check appropriate box.)


          [X]  (a) The reasons described in detail in Part III of 
this form could not be eliminated without unreasonable effort or 
expense;


          [X]  (b) The subject annual report, semi-annual report, 
transition report of Forms 10-K, 10- KSB, 20-F, 11-K or Form N-SAR, 
or portion thereof will be filed on or before the 15th calendar day 
following the prescribed due date; or the subject quarterly report 
or transition report on Form 10-Q, 10-QSB, or portion thereof will 
be filed on or before the fifth calendar day following the 
prescribed due date; and


          [ ]  (c) The accountant's statement or other exhibit 
required by Rule 12b-25(c) has been attached if applicable.


                             PART III

                             NARRATIVE


         State below in reasonable detail the reasons why 
Forms 10-K, 10-KSB, 11-K, 20-F, 10-Q, 10-QSB, N-SAR or the 
transition report portion thereof could not be filed within the 
prescribed time period. (Attach extra sheets if needed.)


         The Registrant's quarterly report on Form 10-QSB could not 
be filed within the prescribed time period because the financial 
statements required to be prepared by the Registrant's 
internal accountant were not completed and made available to the 
Registrant in time for the quarterly report to be filed in a
timely manner.


<PAGE>

                             PART IV

                        OTHER INFORMATION

         (1) Name and telephone number of person to contact in 
regard to this notification:

         Don Brucker             (619)           454-6790
         -----------------      --------------------------------
              (Name)            (Area Code)   (Telephone Number)

         (2) Have all other periodic reports required under 
Section 13 or 15(d) of the Securities Exchange Act of 1934 or 
Section 30 of the Investment Company Act of 1940 during the 
preceding 12 months or for such shorter period that the 
registrant was required to file such report(s) been filed? If the 
answer is no, identify report(s).                          
                    [X]  YES  [ ]  No

         (3) Is it anticipated that any significant change in 
results of operations from the corresponding period for the last 
fiscal year will be reflected by the earnings statements to be 
included in the subject report or portion thereof?
                    [ ]  YES  [X]  No

         If so, attach an explanation of the anticipated change, 
both narratively and quantitatively, and, if appropriate, state 
the reasons why a reasonable estimate of the results cannot be 
made.



Exhibits
- ---------

None

<PAGE>

                   La Jolla Diagnostics, Inc.
               ----------------------------------
           (Name of Registrant as Specified in Charter

         Has caused this notification to be signed on its behalf 
by the undersigned thereunto duly authorized.

Date     November 13, 1998     By /s/ DON BRUCKER
                              ------------------------
                                    Don Brucker
                                    Chairman of the Board, 
                                    Chief Executive Officer
                                    






© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission